TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages
about
T cell integrin overexpression as a model of murine autoimmunityRoles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular DiseaseBone Marrow GvHD after Allogeneic Hematopoietic Stem Cell TransplantationThe Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid ArthritisTRAIL/DR5 signaling promotes macrophage foam cell formation by modulating scavenger receptor expressionInflammation induced loss of skeletal muscleApoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoproteinBAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.Murine models of lupus induced by hypomethylated T cellsMacrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.Fas ligand-expressing lymphocytes enhance alveolar macrophage apoptosis in the resolution of acute pulmonary inflammation.Maternal plasma soluble TRAIL is decreased in preeclampsia.Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection.Urinary biomarkers in lupus nephritis.TWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus.CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Cytolytic pathways in haematopoietic stem-cell transplantation.Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke.Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cellsThe signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia.Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity.Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects.The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targetingIs TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.Helicobacter pylori sensitizes TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIPInterplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflammation and mucosal pathologyCytolytic CD4(+) T cells in viral immunityAberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer.TNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what's new?Theiler's murine encephalomyelitis virus induces apoptosis in gamma interferon-activated M1 differentiated myelomonocytic cells through a mechanism involving tumor necrosis factor alpha (TNF-alpha) and TNF-alpha-related apoptosis-inducing ligand.Normal human primary CD4+ T lymphocytes synthesize and release functional osteoprotegerin in vitro.TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice.Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.Autoreactive murine Th1 and Th2 cells kill syngeneic macrophages and induce autoantibodies.Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors.
P2860
Q24806565-79EAE1EB-1786-4BE3-91B5-742277B43470Q26747224-A8227CB0-AAFF-4781-943B-36C88AAB6E2BQ26749553-D72D2206-D694-4B75-81D2-F76E0617FADCQ26774681-4E644225-FC37-4755-9C82-3311DD831860Q27325727-95822DB4-31EF-4038-A2C9-106090772944Q28083759-896E3705-87FB-410F-B992-4147921602F0Q28472613-F30E3E53-993D-456A-8CD3-A777F59F44EDQ30724766-50E57743-01C8-4967-9C7F-E991CB31333CQ33621000-EA7124E7-0589-462F-B0DD-92607C7D18BCQ33752988-77487F47-1045-45ED-8447-5796486A3300Q33840384-BB541B7C-AC5D-4D2E-BDB3-C71C8299271AQ33909572-86C44653-D8D1-4D31-85DC-1E34C669617CQ33910907-D6669FC4-B143-48F9-8EE1-A2AF6C54FDF2Q34050022-F90F35B4-EEAD-4656-9A5D-925A6A9B59B5Q34206359-842BD102-905D-4AC7-B551-CAD93AB3AF68Q34266298-70C5E65F-855A-443C-B340-CB9E42D2D9A8Q34450860-2B23AED4-E6F8-4AC9-85C4-C5C19F9D4D75Q34632083-3CEAA05E-A58F-4C5D-B16B-A9C34F96DED3Q35763132-6B2F40B4-A62A-46E1-9ACA-95EE1F56B9DDQ35897178-02E6762C-1066-454C-A287-DE3D0D145260Q36076521-3952DAE7-BA1C-4793-8AFE-F77304335A8BQ36302070-305E8D5E-5F20-4FAC-867A-29F7B70C8C29Q36369095-90679B53-9286-4265-89D0-AB62B74EE1D6Q36729652-09EB6EBE-60F8-4DD8-9D59-C6AD5E8A0D8BQ37071856-C2EDC08C-5702-4C8C-862F-359F70B816F1Q37072767-15B8988D-0C17-4313-8746-8C1F860A2D97Q37135363-E79F3D12-E508-47E6-B9F2-320C07D1CC39Q37415529-5ABFAF46-9834-4865-A425-C84FE85859EEQ37486214-98C6950C-A37D-4F3E-A921-F3AEEA0BF4A2Q37680159-99DD1CC1-488B-479A-B1A3-4B12916CBD6CQ37700153-F566F379-4C3F-43F0-90CF-14DA324AF6DEQ37812127-FBD2813B-4937-4558-B47D-864E6FCDD5E6Q38043456-9559F078-E2ED-4900-88AB-1C17DBE9C179Q38070361-BC9A99FE-0C9B-4FF0-90F2-192AC518C999Q39603187-9FDFC503-9461-4A6B-9E86-41A27822BDAFQ40044243-8AA010FE-EB78-4225-830B-78C4F46A23A5Q42100605-6F8CE3BF-FDAB-4283-BADE-83B9B58304E4Q42846938-F532B957-0620-412B-BE4E-0DC55031C8F0Q43725027-83C9E4FC-B3CB-46E5-AFDA-86663D8BAD7FQ44930024-98D3E202-75E9-4921-91F6-CD8EDFCF6D67
P2860
TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@ast
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@en
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@nl
type
label
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@ast
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@en
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@nl
prefLabel
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@ast
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@en
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@nl
P2093
P3181
P1476
TRAIL (Apo2 ligand) and TWEAK ...... antigen-presenting macrophages
@en
P2093
P304
P3181
P356
10.4049/JIMMUNOL.164.6.2897
P407
P577
2000-03-15T00:00:00Z